Raymond James & Associates Edwards Lifesciences Corp Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Raymond James & Associates holds 1,675,733 shares of EW stock, worth $126 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,675,733
Previous 1,825,230
8.19%
Holding current value
$126 Million
Previous $169 Million
34.41%
% of portfolio
0.07%
Previous 0.11%
Shares
30 transactions
Others Institutions Holding EW
# of Institutions
1,350Shares Held
457MCall Options Held
9.76MPut Options Held
3.92M-
Vanguard Group Inc Valley Forge, PA62.6MShares$4.72 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY51MShares$3.84 Billion0.11% of portfolio
-
Wellington Management Group LLP Boston, MA31.5MShares$2.38 Billion0.37% of portfolio
-
State Street Corp Boston, MA26.3MShares$1.98 Billion0.07% of portfolio
-
Geode Capital Management, LLC Boston, MA13.5MShares$1.02 Billion0.07% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $46.6B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...